Jaguar Health, Inc. (JAGX) earnings
Quarterly results of Jaguar Health, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Jaguar Health, Inc. reported revenue of $1.2M (-58.9% on the same quarter a year earlier) and a net loss of $12.7M.
Diluted earnings per share were -$15.70.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $1.2M | -58.9% | -$12.7M | -$15.70 |
| Q1 FY2026 | $20.3M | +815.6% | -$7M | -$13.60 |
| Q4 FY2025 | $3.2M | -7.8% | -$23.2M | - |
| Q3 FY2025 | $3.1M | -0.8% | -$9.5M | -$6.28 |
| Q2 FY2025 | $3M | - | -$10.4M | -$358.94 |
| Q1 FY2025 | $2.2M | - | -$10.5M | -$584.45 |
| Q4 FY2024 | $3.5M | - | -$9.9M | - |
| Q3 FY2024 | $3.1M | - | -$9.9M | -$26.29 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
What were Jaguar Health, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Jaguar Health, Inc. reported revenue of $1.2M and a net loss of $12.7M. The figures come from its filing with the SEC.
Is Jaguar Health, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $1.2M, down 58.9% from $3M in the same quarter a year earlier.
Get an email when JAGX reports
Follow JAGX and we email you its next results the day they are filed, with the numbers explained.